BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38244700)

  • 1. Disease diagnosis and severity classification in pulmonary fibrosis using carbonyl volatile organic compounds in exhaled breath.
    Taylor MJ; Chitwood CP; Xie Z; Miller HA; van Berkel VH; Fu XA; Frieboes HB; Suliman SA
    Respir Med; 2024 Feb; 222():107534. PubMed ID: 38244700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Idiopathic Pulmonary Fibrosis and Prediction of Disease Severity via Machine Learning Analysis of Comprehensive Metabolic Panel and Complete Blood Count Data.
    Mueller AN; Miller HA; Taylor MJ; Suliman SA; Frieboes HB
    Lung; 2024 Apr; 202(2):139-150. PubMed ID: 38376581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volatile Organic Compounds in Exhaled Breath of Idiopathic Pulmonary Fibrosis for Discrimination from Healthy Subjects.
    Yamada YI; Yamada G; Otsuka M; Nishikiori H; Ikeda K; Umeda Y; Ohnishi H; Kuronuma K; Chiba H; Baumbach JI; Takahashi H
    Lung; 2017 Apr; 195(2):247-254. PubMed ID: 28247041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of exhaled air analysis in discriminating interstitial lung diseases: a pilot study.
    Plantier L; Smolinska A; Fijten R; Flamant M; Dallinga J; Mercadier JJ; Pachen D; d'Ortho MP; van Schooten FJ; Crestani B; Boots AW
    Respir Res; 2022 Jan; 23(1):12. PubMed ID: 35057817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
    Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
    J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breath carbonyl compounds as biomarkers of lung cancer.
    Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA
    Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
    Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
    Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of a Broad Range of Carbonyl Metabolites in Exhaled Breath by UHPLC-MS.
    Xie Z; Morris JD; Mattingly SJ; Sutaria SR; Huang J; Nantz MH; Fu XA
    Anal Chem; 2023 Mar; 95(9):4344-4352. PubMed ID: 36815760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary method for profiling volatile organic compounds in breath that correlate with pulmonary function and other clinical traits of subjects diagnosed with cystic fibrosis: a pilot study.
    Woollam M; Siegel AP; Grocki P; Saunders JL; Sanders DB; Agarwal M; Davis MD
    J Breath Res; 2022 Feb; 16(2):. PubMed ID: 35120338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can exhaled nitric oxide differentiate causes of pulmonary fibrosis?
    Guilleminault L; Saint-Hilaire A; Favelle O; Caille A; Boissinot E; Henriet AC; Diot P; Marchand-Adam S
    Respir Med; 2013 Nov; 107(11):1789-96. PubMed ID: 24011803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive detection of lung cancer using exhaled breath.
    Fu XA; Li M; Knipp RJ; Nantz MH; Bousamra M
    Cancer Med; 2014 Feb; 3(1):174-81. PubMed ID: 24402867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Ability of Electronic Nose Technology to Recognize Interstitial Lung Diseases (ILD) by Non-Invasive Breath Screening of Exhaled Volatile Compounds (VOC): A Pilot Study from the European IPF Registry (eurIPFreg) and Biobank.
    Krauss E; Haberer J; Maurer O; Barreto G; Drakopanagiotakis F; Degen M; Seeger W; Guenther A
    J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31623141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.
    Feng H; Zhao Y; Li Z; Kang J
    Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of exhaled carbonyl compounds distinguishes benign from malignant pulmonary disease.
    Bousamra M; Schumer E; Li M; Knipp RJ; Nantz MH; van Berkel V; Fu XA
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1074-80; discussion 1080-1. PubMed ID: 25129599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
    Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
    Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in lung epithelial cell volatile metabolite profile induced by pro-fibrotic stimulation with TGF-
    Hayton C; Ahmed W; Cunningham P; Piper-Hanley K; Pearmain L; Chaudhuri N; Leonard C; Blaikley JF; Fowler SJ
    J Breath Res; 2023 Sep; 17(4):. PubMed ID: 37619557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Rcn3 level is a potential diagnostic biomarker for connective tissue disease-associated interstitial lung disease and reflects the severity of pulmonary function.
    Ding F; Yang L; Wang Y; Wang J; Ma Y; Jin J
    BMC Pulm Med; 2023 Feb; 23(1):68. PubMed ID: 36800954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease.
    Cameli P; Bargagli E; Bergantini L; Refini RM; Pieroni M; Sestini P; Rottoli P
    J Breath Res; 2019 Mar; 13(2):026008. PubMed ID: 30690441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between lung function and exhaled volatile organic compounds in healthy infants.
    Sola-Martínez RA; Sanchez-Solis M; Lozano-Terol G; Gallego-Jara J; García-Marcos L; Cánovas Díaz M; de Diego Puente T;
    Pediatr Pulmonol; 2022 May; 57(5):1282-1292. PubMed ID: 35092361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative Stress Biomarkers in Exhaled Breath of Workers Exposed to Crystalline Silica Dust by SPME-GC-MS.
    Jalali M; Zare Sakhvidi MJ; Bahrami A; Berijani N; Mahjub H
    J Res Health Sci; 2016; 16(3):153-161. PubMed ID: 27840344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.